ImmunityBio, Inc. Revenue 2013–2025

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

ImmunityBio, Inc. annual/quarterly revenue history and growth rate from 2013 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

ImmunityBio, Inc. revenue for the quarter ending March 31, 2026 was 44.2 M, a 167.64% increase year-over-year.
ImmunityBio, Inc. revenue for the twelve months ending March 31, 2026 was 119.2 M, a 1538.61% increase year-over-year.
ImmunityBio, Inc. annual revenue for 2025 was 113.3 M, a 668.31% increase from 2024.
ImmunityBio, Inc. annual revenue for 2024 was 14.7 M, a 2270.58% increase from 2023.
ImmunityBio, Inc. annual revenue for 2023 was 622000, a 159.17% increase from 2022.
ImmunityBio, Inc. annual revenue for 2022 was 240000.

Revenue

TRAILING 12 MONTHS · $B

QUARTERLY · $B

YEAR-OVER-YEAR GROWTH · %

ImmunityBio, Inc. Market Cap — FAQ

ImmunityBio, Inc. (IBRX) market cap over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see IBRX's market cap history?

The chart and table above show ImmunityBio, Inc.'s market cap by year and by quarter, including the growth rate.